Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,243
Closed -$1.38M 908
2021
Q1
$1.38M Sell
18,243
-8,367
-31% -$613K 0.01% 363
2020
Q4
$1.75M Sell
26,610
-3,370
-11% -$197K 0.02% 317
2020
Q3
$1.62M Sell
29,980
-10,574
-26% -$581K 0.02% 259
2020
Q2
$1.95M Sell
40,554
-11,039
-21% -$488K 0.03% 241
2020
Q1
$1.76M Sell
51,593
-7,437
-13% -$409K 0.03% 225
2019
Q4
$3.7M Sell
59,030
-67,570
-53% -$3.82M 0.03% 179
2019
Q3
$6.33M Buy
126,600
+110,622
+692% +$5.22M 0.05% 132
2019
Q2
$771K Sell
15,978
-123,869
-89% -$5.96M 0.01% 392
2019
Q1
$7.14M Buy
+139,847
New +$6.13M 0.05% 138

Other funds holding ENOV

ALPS Advisors's ENOV Position: Q2 2021 in Review

ALPS Advisors sold out of Enovis (ENOV) in Q2 2021, closing a stake of 18,243 shares — an estimated $1.38M sold.

ALPS Advisors first reported a position in ENOV in Q1 2019 and held it in 9 quarters. The position peaked at $7.14M in Q1 2019. 277 funds tracked by Wall St. Rank hold ENOV as of Q2 2021.

  • ALPS Advisors reported no remaining Enovis position as of Q2 2021 after selling out during the quarter.
  • ALPS Advisors sold 18,243 Enovis shares in Q2 2021, an estimated $1.38M.
  • ALPS Advisors first reported a position in Enovis in Q1 2019 and held it in 9 quarters.
  • ALPS Advisors's Enovis position peaked at $7.14M in Q1 2019.
  • 277 funds tracked by Wall St. Rank held Enovis as of Q2 2021.

Based on ALPS Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.